MARY GIBSON: Open Payments
NPI 1346301918 · OREGON CITY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 24 payments from 8 companies in 2025. Trend: 2023 $307 · 2024 $330 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Lundbeck LLC | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 1 | $37 |
| Exact Sciences Corporation | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $30 |
Products named: REXULTI, CAPLYTA, FANAPT, ABILIFY ASIMTUFII, COBENFY, The Cologuard Plus Collection Kit, TRINTELLIX, ARISTADA.
Industry payments across OR — which companies pay providers there.
